Association of metals and proteasome activity in erythrocytes of prostate cancer patients and controls

Biological Trace Element Research

Volumn 149, Issue 1, 2012, Pages 5-9

  Neslund Dudas, Christine ^a,b,d   Mitra, Bharati ^c   Kandegedara, Ashoka ^c   Chen, Di ^c   Schmitt, Sara ^c   Shen, Min ^c   Cui, Qiuzhi ^c   Rybicki, Benjamin A ^a,b   Dou, Q Ping ^b,c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

Arsenic; Cadmium; Copper; Erythrocyte; Lead; Metal; Prostate cancer; Proteasome activity; Zinc

Indexed keywords

ARSENIC; CADMIUM; CHYMOTRYPSIN; COPPER; DNA 26S; LEAD; METAL; PROTEASOME; ZINC;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CELL PROLIFERATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ERYTHROCYTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PROSTATE CANCER; PROTEIN DEGRADATION;

ADULT; AGED; ARSENIC; CADMIUM; CASE-CONTROL STUDIES; CHYMOTRYPSIN; COPPER; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVATION; ERYTHROCYTES; GENE-ENVIRONMENT INTERACTION; HUMANS; LEAD; MALE; MASS SPECTROMETRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 84866135332     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-012-9391-z     Document Type: Article

References (26)

1. Ambroggio XI, Rees DC, Deshaies RJ (2004) JAMM: a metalloprotease-like zinc site in the proteasome and signalosome. PLoS Biol 2:E2
2. Bardag-Gorce F, French SW (2011) Delta-aminolevulinic dehydratase is a proteasome interacting protein. Exp Mol Pathol 91:485-489
3. Chang TL, Chang CJ, Lee WY, Lin MN, Huang YW, Fan K (2009) The roles of ubiquitin and 26S proteasome in human obesity. Metabolism 58:1643-1648
4. Hope AD, de Silva R, Fischer DF, Hol EM, van Leeuwen FW, Lees AJ (2003) Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression. J Neurochem 86:394-404
5. Marfella R, Filippo CD, Portoghese M, Siniscalchi M, Martis S, Ferraraccio F, Guastafierro S, Nicoletti G, Barbieri M, Coppola A, Rossi F, Paolisso G, D'Amico M (2009) The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control. Cardiovasc Pathol 18:332-345
6. Ostrowska H, Hempel D, Holub M, Sokolowski J, Kloczko J (2008) Assessment of circulating proteasome chymotrypsin-like activity in plasma of patients with acute and chronic leukemias. Clin Biochem 41:1377-1383
7. Xiao Y, Chen D, Zhang X, Cui Q, Fan Y, Bi C, Dou QP (2010) Molecular study on copper-mediated tumor proteasome inhibition and cell death. Int J Oncol 37:81-87
8. Cvek B, Milacic V, Taraba J, Dou QP (2008) Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells. J Med Chem 51:6256-6258
9. Milacic V, Fregona D, Dou QP (2008) Gold complexes as prospective metal-based anticancer drugs. Histol Histopathol 23:101-108
10. Kona F, Buac D, Burger A (2011) Disulfiram, and disulfiram derivatives as novel potential anticancer drugs targeting the ubiquitin-proteasome system in both preclinical and clinical studies. Curr Cancer Drug Targets 11:338-346
11. Chen D, Cui QC, Yang H, Dou QP (2006) Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res 66:10425-10433
12. Milacic V, Chen D, Giovagnini L, Diez A, Fregona D, Dou QP (2008) Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity. Toxicol Appl Pharmacol 231:24-33
13. Li L, Yang H, Chen D, Cui C, Dou QP (2008) Disulfiram promotes the conversion of carcinogenic cadmium to a proteasome inhibitor with pro-apoptotic activity in human cancer cells. Toxicol Appl Pharmacol 229:206-214
14. Kisselev AF, Callard A, Goldberg AL (2006) Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J Biol Chem 281:8582-8590
15. Neslund-Dudas C, Bock CH, Monaghan K, Nock NL, Yang JJ, Rundle A, Tang D, Rybicki BA (2007) SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness. Prostate 67:1654-1663
16. Costello LC, Franklin RB (2011) Zinc is decreased in prostate cancer: an established relationship of prostate cancer! J Biol Inorg Chem 16:3-8
17. Tisato F, Marzano C, Porchia M, Pellei M, Santini C (2010) Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev 30:708-749
18. Verani CN (2012) Metal complexes as inhibitors of the 26S proteasome in tumor cells. J Inorg Biochem 106:59-67
19. Schrauzer GN (2009) Selenium and selenium-antagonistic elements in nutritional cancer prevention. Crit Rev Biotechnol 29:10-17
20. Schopfer J, Drasch G, and Schrauzer, GN (2010) Selenium and cadmium levels and ratios in prostates, livers, and kidneys of nonsmokers and smokers. Biol Trace Elem Res 134:180-7
21. Drasch G, Schopfer J, Schrauzer GN (2005) Selenium/cadmium ratios in human prostates: indicators of prostate cancer risk of smokers and nonsmokers, and relevance to the cancer protective effects of selenium. Biol Trace Elem Res 103:103-107
22. Sarafanov AG, Todorov TI, Centeno JA, Macias V, Gao W, Liang WM, Beam C, Gray MA, Kajdacsy-Balla AA (2011) Prostate cancer outcome and tissue levels of metal ions. Prostate 71:1231-1238
23. Wang F, Zhai S, Liu X, Li L, Wu S, Dou QP, Yan B (2011) A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells. Cancer Lett 300:87-95
24. 2+ exposure does not induce degradation of alpha-synuclein. J Environ Pathol Toxicol Oncol 28:5-24
25. Guo GG, Gu M, Etlinger JD (1994) 240-kDa proteasome inhibitor (CF-2) is identical to delta-aminolevulinic acid dehydratase. J Biol Chem 269:12399-12402
26. Goldstein DH, Kneip TJ, Rulon VP, Cohen N (1975) Erythrocytic aminolevulinic acid dehydratase (ALAD) activity as a biologic parameter for determining exposures to lead. J Occup Med 17:157-162